Patent · US Active

Process for the preparation of norelgestromin

US7393964B2 · kind B2 · utility

1Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2006
Grant dateJul 1, 2008
Priority date
Expiry dateDec 20, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P15/18
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Process for the preparation of Norelgestromin or 17α-hydroxy-13β-ethyl-18,19-dinorpregn-4-ene-20-yn-3-one oxime, also in crystalline form, in particular with an E/Z isomer ratio of between 1.3 and 1.5.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.